TANK
Basic information
Region (hg38): 2:161136908-161236230
Previous symbols: [ "TRAF2" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the TANK gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 23 | 25 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 1 | ||||
non coding | 0 | |||||
Total | 0 | 0 | 23 | 0 | 3 |
Variants in TANK
This is a list of pathogenic ClinVar variants found in the TANK region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
2-161203511-C-T | not specified | Uncertain significance (Feb 16, 2023) | ||
2-161204726-A-G | not specified | Uncertain significance (Jan 23, 2024) | ||
2-161204747-C-A | not specified | Uncertain significance (Mar 05, 2024) | ||
2-161204762-T-C | not specified | Uncertain significance (Mar 25, 2024) | ||
2-161204791-A-G | not specified | Uncertain significance (Jul 08, 2022) | ||
2-161223924-C-G | Benign (Dec 01, 2022) | |||
2-161230995-A-C | not specified | Uncertain significance (Apr 07, 2023) | ||
2-161231017-A-T | not specified | Uncertain significance (Aug 11, 2022) | ||
2-161231044-T-C | Benign (Mar 29, 2018) | |||
2-161231061-G-C | not specified | Uncertain significance (Jun 24, 2022) | ||
2-161231121-C-T | not specified | Uncertain significance (Jan 02, 2024) | ||
2-161231150-G-T | not specified | Uncertain significance (Mar 06, 2023) | ||
2-161231167-G-A | not specified | Uncertain significance (Aug 16, 2022) | ||
2-161231178-C-T | not specified | Uncertain significance (Jul 29, 2022) | ||
2-161231196-C-T | not specified | Uncertain significance (Nov 09, 2022) | ||
2-161231268-T-C | not specified | Uncertain significance (Feb 06, 2023) | ||
2-161231315-G-A | not specified | Uncertain significance (Jun 21, 2022) | ||
2-161231332-C-A | not specified | Uncertain significance (May 11, 2022) | ||
2-161231348-A-G | not specified | Uncertain significance (Sep 27, 2022) | ||
2-161231356-C-G | not specified | Uncertain significance (Jun 22, 2021) | ||
2-161231364-C-A | not specified | Uncertain significance (May 28, 2023) | ||
2-161231370-A-G | not specified | Uncertain significance (Sep 17, 2021) | ||
2-161231406-T-G | not specified | Uncertain significance (Jul 08, 2022) | ||
2-161231430-C-T | not specified | Uncertain significance (Mar 02, 2023) | ||
2-161231468-A-C | not specified | Uncertain significance (Nov 29, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
TANK | protein_coding | protein_coding | ENST00000392749 | 7 | 99314 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.838 | 0.162 | 125739 | 0 | 5 | 125744 | 0.0000199 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.32 | 162 | 217 | 0.748 | 0.0000106 | 2797 |
Missense in Polyphen | 42 | 60.837 | 0.69037 | 774 | ||
Synonymous | 0.379 | 77 | 81.4 | 0.946 | 0.00000442 | 805 |
Loss of Function | 3.42 | 3 | 19.2 | 0.156 | 9.70e-7 | 236 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000353 | 0.0000352 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.0000327 | 0.0000327 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Adapter protein involved in I-kappa-B-kinase (IKK) regulation which constitutively binds TBK1 and IKBKE playing a role in antiviral innate immunity. Acts as a regulator of TRAF function by maintaining them in a latent state. Blocks TRAF2 binding to LMP1 and inhibits LMP1-mediated NF-kappa-B activation. Negatively regulates NF-kappaB signaling and cell survival upon DNA damage (PubMed:25861989). Plays a role as an adapter to assemble ZC3H12A, USP10 in a deubiquitination complex which plays a negative feedback response to attenuate NF-kappaB activation through the deubiquitination of IKBKG or TRAF6 in response to interleukin-1-beta (IL1B) stimulation or upon DNA damage (PubMed:25861989). Promotes UBP10-induced deubiquitination of TRAF6 in response to DNA damage (PubMed:25861989). May control negatively TRAF2-mediated NF-kappa-B activation signaled by CD40, TNFR1 and TNFR2. {ECO:0000269|PubMed:12133833, ECO:0000269|PubMed:21931631, ECO:0000269|PubMed:25861989}.;
- Pathway
- NOD-like receptor signaling pathway - Homo sapiens (human);RIG-I-like receptor signaling pathway - Homo sapiens (human);TNF alpha Signaling Pathway;Structural Pathway of Interleukin 1 (IL-1);RIG-I-like Receptor Signaling;tnfr2 signaling pathway;tnf/stress related signaling;TICAM1-dependent activation of IRF3/IRF7;Toll Like Receptor 3 (TLR3) Cascade;Toll-Like Receptors Cascades;TRAF6 mediated IRF7 activation;DDX58/IFIH1-mediated induction of interferon-alpha/beta;Innate Immune System;Immune System;TNFalpha;Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon;TRIF(TICAM1)-mediated TLR4 signaling ;MyD88-independent TLR4 cascade ;Toll Like Receptor 4 (TLR4) Cascade
(Consensus)
Recessive Scores
- pRec
- 0.183
Intolerance Scores
- loftool
- 0.328
- rvis_EVS
- 0.48
- rvis_percentile_EVS
- 79.25
Haploinsufficiency Scores
- pHI
- 0.324
- hipred
- Y
- hipred_score
- 0.701
- ghis
- 0.524
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.849
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Tank
- Phenotype
- renal/urinary system phenotype; liver/biliary system phenotype; respiratory system phenotype; hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); immune system phenotype;
Gene ontology
- Biological process
- proteolysis;cellular response to DNA damage stimulus;signal transduction;I-kappaB kinase/NF-kappaB signaling;viral process;TRIF-dependent toll-like receptor signaling pathway;negative regulation of I-kappaB kinase/NF-kappaB signaling;cellular response to interleukin-1;cellular response to tumor necrosis factor;cellular response to ionizing radiation;positive regulation of protein deubiquitination;positive regulation of ubiquitin-specific protease activity
- Cellular component
- cytosol;protein-containing complex
- Molecular function
- thiol-dependent ubiquitin-specific protease activity;protein binding;ubiquitin protein ligase binding;deubiquitinase activator activity;metal ion binding